Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, ...

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

We recently compiled a list of the Jim Cramer Discusses These 10 Stocks & Comments On OpenAI’s Valuation. In this article, we ...

We recently published a list of Jim Cramer’s February Portfolio: Top 10 Stocks. In this article, we are going to take a look ...

John Lilly and the Earth Coincidence Control Office’ from Michael Almereyda and Courtney Stephens, narrated by Chloë Sevigny, debuts at Rotterdam, exploring the life of the utopian neuroscientist.

Shares of Eli Lilly & Co. were headed for their worst day ... acceleration of growth for the quarter,” said Chief Executive David Ricks. Tomi Kilgore is MarketWatch's deputy investing and ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Eli Lilly’s CEO David Ricks reported that the company’s experimental weight loss drug, orforglipron, is anticipated to receive regulatory approval as early as the beginning of next year.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

In it, David Lynch, who died at age 78, jimmied up the floorboards of the American dream and loosed a swarm of evil spirits from beneath. But “Twin Peaks,” which Lynch made with Mark Frost ...

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.

Eli Lilly pre-announced a sizable Q4 2024 revenue ... In the pre-announcement press release, CEO David Ricks highlighted the substantial production growth forecast for the 1H of 2025 as follows ...